Best Genomics Companies in Netherlands
The 103 best Genomics companies in Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: UniQure.
Netherlands genomics is where I'd tell you to look if you want proof that deep-science funding can concentrate fast. This directory ranks the best Genomics companies in Netherlands by disclosed equity funding and recent funding momentum, tracking 103 companies across a sector that's expanding hard globally, forecast to reach roughly $85B by 2030 at a 16.37% CAGR. Total disclosed funding across the cohort sits at $355M. No unicorns yet, but the concentration at the top is striking: UniQure alone accounts for $111M, Lumicks follows at $93M, and InteRNA Technologies adds $33M. Three companies, most of the pool.
So what's driving the next wave? Hereditary disease genomics, pharmacogenomics, and machine-learning drug discovery are the hot themes right now, and declining sequencing costs are pulling more capital into the space than government mandates alone ever could. And it's not just Europe: Mukesh Ambani flagging genomics as a pillar of India's economic future signals how global the conversation has gotten. Active investors here, including Europa, EIC Fund, Oost NL, EQT, and Aglaia, are watching that same macro current. The companies below are the ones worth knowing.
- Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 202
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Netherlands
| # | Company | Disclosed funding | Last round | Employees | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | UniQure Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | 62 mo ago | 501 | Matthew Kapusta CEO | 18 signals Earnings · Funding · FDA approval | 328 patents Engineering AAV vectors and liver-specific promoters for gene therapy applications | — |
| 2 | LUMICKS Manufacturer of optical tweezers for single molecule analysis instruments | $93M | 20 mo ago | 263 | Andrea Candelli Co-Founder | — | — | 1 launch |
| 3 | InteRNA Technologies Discovering and developing microRNA (miRNA)-based therapeutics for oncology | $33M | 64 mo ago | 13 | — | — | 20 patents Patents concentrated in chemistry & materials | — |
| 4 | Xpand Biotechnology Developer of alternative bio-reactors for 2D cell culture | $17M | 107 mo ago | 15 | Joost De Bruijn Founder | — | 19 patents Single-use bioreactors with pH/gas control and osteoinductive calcium‑phosphate biomaterials | — |
| 5 | Bluebee Provider of solutions for genomics data analysis | $13M | 122 mo ago | 31 | — | — | — | — |
| 6 | Amarna Therapeutics Developer of immune-modulating gene therapies for rare and prevalent autoimmune diseases and genetic diseases | $11M | 80 mo ago | 30 | Marjanne Messie CFO | — | 5 patents Patents concentrated in chemistry & materials | — |
| 7 | Photanol Provider of technology for light-powered bio-production of chemicals | $9M | 54 mo ago | 39 | — | — | 27 patents Photosynthetic microbial synthesis of platform chemicals (propylene, glycolate, 1,3‑propanediol, erythritol). | — |
| 8 | ORCA Therapeutics Provider of virus mediated immunotherapy for cancer | $9M | 121 mo ago | 4 | — | — | 9 patents Patents concentrated in chemistry & materials | — |
| 9 | ProteoNic Provider of products and services for improving recombinant protein production levels | $8M | 176 mo ago | 20 | Frank Pieper CEO | — | — | — |
| 10 | InnoSIGN Developer of mRNA-based diagnosis platform for precision medicine | $8M | 51 mo ago | 16 | Paul Van De Wiel Chief Operating Officer | Co-Founder | — | 50 patents Computational biomarkers for signaling pathway activity in oncology and infectious disease | — |
| 11 | Topigs Norsvin Provider of swine genetics focused on sustainable and cost-efficient pig production | $7M | 60 mo ago | 201 | Villaume Kal CEO | — | — | — |
| 12 | Hudson River Biotechnology Developer of DNA-free CRISPR technology for crop resilience and yield improvement | $6M | 26 mo ago | 30 | — | — | 4 patents Encapsulation particles for delivering hydrophilic/amphiphilic bio‑compounds | — |
| 13 | Facio Therapies Provider of small molecule therapeutics for Facioscapulohumeral Dystrophy | $3M | 128 mo ago | 7 | David Dasberg CEO | — | — | — |
| 14 | Genewity Biotech company focused on commercializing potentially groundbreaking therapies in the field of cell and gene… | $3M | 39 mo ago | — | Arno Bisschop Co-Founder & CEO | — | 2 patents Artificial thymus creation for immune cell therapy and regenerative immunology | — |
| 15 | Kreatech Developer of novel FISH probes for detection and quantification | $3M | 198 mo ago | — | Kees Moonen CEO | — | — | — |
| 16 | Cergentis Provider of kits and services for the targeted sequencing of genes | $3M | 73 mo ago | 39 | — | — | 41 patents 3D genome region sequencing and targeted copy-number heterogeneity analysis | — |
| 17 | SkylineDX Provider of gene expression profiling tests for personalized medicine | $2M | 54 mo ago | 61 | Dharminder Chahal CEO | — | 27 patents Predictive gene expression biomarkers for melanoma metastasis and treatment response | — |
| 18 | Phenospex Developer of digital plant phenotyping sensors and automated crop analysis | $2M | 95 mo ago | 28 | — | — | 20 patents Optical object detection and laser‑triangulation imaging for precise agricultural/industrial sensing | — |
| 19 | Bio-Prodict Developer of a bioinformatics computational platform for the analysis of biological data | $2M | 60 mo ago | — | Henk-Jan Joosten CEO & Owner | — | — | — |
| 20 | Scope Biosciences Developer of CRISPR-Cas based diagnostic platform | $2M | 31 mo ago | 8 | Stijn Prinsen Co-Founder | — | 4 patents Type III CRISPR/Cas molecular diagnostic assays for nucleic acid detection | — |
| 21 | TherageniX Developer of non-viral delivery system for tissue regeneration | $1M | 33 mo ago | — | Anandkumar Nandakumar Co-Founder & CEO | — | — | — |
| 22 | GenomeScan Provider of next-generation genome sequencing and testing | $1M | 43 mo ago | 38 | Peter Belt CEO | — | — | 1 job opening · 1 internship |
| 23 | BaseClear Contract service laboratory with a focus on DNA technology, genomics and synthetic biology. | $1M | 82 mo ago | 96 | — | — | — | 2 job openings · 1 internship |
| 24 | Future Diagnostics Manufacturer of in-vitro diagnostic assay | $933K | 113 mo ago | 64 | — | — | 27 patents Immunoassay kits and reagents for measuring free 25‑hydroxy vitamin D in blood. | — |
| 25 | Hendrix Genetics Provider of breeding programs for multiple animal species and related technologies | $856K | 27 mo ago | 3,500 | — | — | 23 patents Pooled sample methods for high‑throughput genetic and biological assay diagnostics | 1 job opening |
| 26 | Innosieve Diagnostics Provider of microbial diagnostic test kits | $769K | 62 mo ago | 3 | — | — | 5 patents Microfilter centrifuge tubes for enhanced sample filtration and separation in laboratory diagnostics | — |
| 27 | 20Med Therapeutics Develops RNA-based therapeutics and vaccines for drug delivery | $736K | 37 mo ago | 13 | Michiel Lodder CEO | — | 15 patents Patents concentrated in chemistry & materials | — |
| 28 | PharmaCell Provider of cell therapy and regenerative medicine CDMO | $504K | 125 mo ago | 75 | — | — | — | — |
| 29 | Amylon Developer of RNA therapeutics for rare beta-amyloid related diseases | $348K | 103 mo ago | 2 | Daniel de Boer Co-Founder | — | — | — |
| 30 | Imuno Therapeutics Developer of drug discovery and precision therapy platform for oncology | $340K | 55 mo ago | 5 | Jan Verhoef Founder | — | — | — |
| 31 | MicroDish Developer of microchips and reagents for microbial cell culture | $282K | 115 mo ago | 4 | Colin Ingham Founder & CSO | — | 5 patents Rapid bacterial detection methods and microbial growth chamber technologies | — |
| 32 | Mercurna Developer of mRNA based therapeutics | $197K | 77 mo ago | — | Jurgen Dieker Co-Founder & CSO | — | — | — |
| 33 | Frame Therapeutics Developer of immunotherapies for cancer treatment | $111K | 76 mo ago | 13 | Bob Lowenberg Co-Founder | — | — | — |
Top 12 Genomics companies in Netherlands
#1
Series D · Amsterdam, North Holland · founded 2014 · 263 employees$93.4Mraised▾
Manufacturer of optical tweezers for single-molecule analysis instruments. The product portfolio of the company includes C-Trap, an integrated system with optical tweezers, a confocal microscope, and a microfluidic system to analyze protein folding, DNA repair, DNA organization, Protein polymer, and filaments. Its product, AFS-acoustic force spectroscopy (a single molecule manipulation system), and u-Flux (an integrated microfluidic system) are used in performing experiments in a laminar flow environment.
- Oct 2024Venture Debt$21.9M
- Jan 2023Grant (prize money)$294.3K
- Sep 2022Grant (prize money)$48.7K
- Apr 2021Series D$93.4M
#2
Series A · Wageningen, Gelderland · founded 2015 · 30 employees$5.9Mraised▾
Developer of DNA-free CRISPR technology for crop resilience and yield improvement. The technology optimizes plant breeding to power and protect future crops. It offers a DNA-free CRISPR method that overcomes traditional limitations. The BioMaas platform allows for multi-trait targeting and scalable automation. Products are completed efficiently once the BioMaas platform has been implemented.
- Apr 2024Series A—
- Aug 2021Series A$5.9M
- Mar 2018Seed—
- Dec 2015Grant (prize money)$54.6K
#3
Public · Amsterdam, North Holland · founded 1998 · 501 employees$111Mraised▾
Developer of gene-based therapies for patients with genetic or acquired diseases. It has developed adeno-associated virus-based gene therapies through its technology platform for multiple therapeutic areas. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency. It also develops AMT-060, gene therapy for the treatment of hemophilia B; S100A1 for congestive heart failure. Other offerings are AMT-021 gene therapy for acute intermittent porphyria, AMT-110, gene therapy for Sanfilippo B syndrome. It also offers AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease.
- Apr 2021Grant (prize money)$534K
- Apr 2015Post IPO$88.5M
- Apr 2015PE$53M
- Jul 2014Venture Debt$20M
#4
Deadpooled · Nijmegen, Gelderland · founded 2006 · 13 employees$32.9Mraised▾
Discovering and developing microRNA (miRNA)-based therapeutics for oncology. Developed a promising platform for the discovery and validation of miRNA-based drug candidates against previously undruggable targets in cancer. The product pipeline includes INT-5A2, INT-1B3 for the treatment of patients with liver cancer and skin cancer. It also developed various programs for pancreatic cancer, head and neck cancer, and bladder cancer.
- Feb 2021Series B$22.4M
- Jan 2021Grant (prize money)$325.7K
- Nov 2015Series A$10.5M
- Mar 2013Series A—
#5
Acquired · Boxmeer, North Brabant · founded 2005 · 3500 employees$855.6Kraised▾
Provider of breeding programs for multiple animal species and related technologies. The company focuses on genetics for laying hens, turkeys, swine, salmon, shrimp, and trout. It aims to develop sustainable solutions for the animal protein value chain. The company's programs are based on breeding philosophies tailored to each market.
- Mar 2024Grant (prize money)—
- Jan 2022Grant (prize money)$170.1K
- Nov 2021PE—
- Jul 2019Grant (prize money)$388K
#6
Seed · Wageningen, Gelderland · founded 2019 · 8 employees$1.7Mraised▾
Developer of CRISPR-Cas based diagnostic platform. The company's scopeDx platform uses proprietary Type III CRISPR-Cas nucleases to detect nucleic acid sequences to detect genetic material with single nucleotide specificity.
- Oct 2023Seed$531.5K
- Sep 2022Grant (prize money)—
- Nov 2021Seed$1.2M
#7
Series A · Amsterdam, North Holland · founded 2008 · 39 employees$9.3Mraised▾
Provider of technology for light-powered bio-production of chemicals. The company is developing a platform technology that uses genetically modified cyanobacteria to directly convert carbon dioxide into specific high-value chemicals. It used for different plastics, the ingredients for personal care products and detergents
- Nov 2021Grant (prize money)$56.4K
- Dec 2019Grant (prize money)$2.5M
- Sep 2018Series A$9.3M
- Jan 2018Grant (prize money)$214.2K
#8
Funding Raised · Leiden, South Holland · founded 2022$3.1Mraised▾
Biotech company focused on commercializing potentially groundbreaking therapies in the field of cell and gene therapies.
- Mar 2023Grant (prize money)$3.1M
#9
Series A · Eindhoven, North Brabant · founded 2021 · 16 employees$8Mraised▾
Developer of mRNA-based diagnosis platform for precision medicine. The company uses a proprietary mRNA-based OncoSIGNal pathway to obtain insights into the mechanisms of disease and provides support to diagnostics and drug development. The technology has application to develop targeted therapies for cancer.
- Mar 2022Series A$8M
#10
Acquired · Bilthoven, Utrecht · founded 2004 · 15 employees$17.1Mraised▾
Xpand biotech has developed mini-bioreactors for cell culture as an alternative to the 2D cell culture system. Also, the company has used the system to study regenerative medicine, with a focus on bone tissue regeneration using calcium phosphate-based material, that has osteoconductive properties.
- Jun 2017Grant (prize money)$2.1M
- Jan 2017Grant (prize money)$1.1M
- Jul 2015Grant (prize money)$2M
- Feb 2007Grant (prize money)$7.1M
#11
Funding Raised · The Hague, South Holland · founded 2022$1.2Mraised▾
Developer of non-viral delivery system for tissue regeneration. The company uses proprietary technology to deliver genes that can instruct the body to produce relevant proteins or factors that help in tissue regeneration.
- Sep 2023Grant (prize money)$1.2M
#12
Funding Raised · Helvoirt, North Brabant · founded 2014 · 201 employees$6.6Mraised▾
Provider of swine genetics focused on sustainable and cost-efficient pig production. The company offers genetic solutions designed to help customers produce nutritious pork. Advanced research and innovation are used to help pork producers achieve production efficiency, meat quality, and animal health. The company provides a range of boars and sows to meet different production environments.
- Jun 2021Grant (prize money)$309.7K
- Jan 2018Conventional Debt$6M
- Mar 2015Grant (prize money)$342.3K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.